Work

Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Blocks Hairy Cell Leukemia (HCL) Survival, Proliferation, and BCR Signaling: A New Therapeutic Approach for HCL

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.1802.1802

Authors: Mariela Sivina, Robert J. Kreitman, Evgeny Arons, Joseph J. Buggy, Farhad Ravandi, Jan A. Burger

Institutions: The University of Texas MD Anderson Cancer Center, National Institutes of Health, National Cancer Institute, Pharmacyclics (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2581664352

FWCI: 0.974

Cites:

Cited by: 9

Related to: 10